Forte Biosciences推出公开募股

Forte Biosciences (NASDAQ:FBRX) has initiated an underwritten public offering of common stock and pre-funded warrants.

Certain investors may receive pre-funded warrants instead of common stock.

Underwriters may be granted a 30-day option to purchase an additional 15% of offered securities.

All securities in the offering are being sold by Forte.

Proceeds will support working capital, clinical and preclinical development, and research activities.

Source: Press release